OraSure Technologies, Inc. (OSUR)
USD 3.79
(-2.07%)
USD 3.79
(-2.07%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -276.9 Million USD | -287.64% |
| 2022 | -71.43 Million USD | 31.64% |
| 2021 | -104.48 Million USD | 32.45% |
| 2020 | -154.67 Million USD | -120.53% |
| 2019 | -70.13 Million USD | 20.69% |
| 2018 | -88.43 Million USD | -21.37% |
| 2017 | -72.86 Million USD | 33.63% |
| 2016 | -109.79 Million USD | -16.68% |
| 2015 | -94.09 Million USD | -1.32% |
| 2014 | -92.86 Million USD | 0.35% |
| 2013 | -93.19 Million USD | -6.03% |
| 2012 | -87.88 Million USD | -429.89% |
| 2011 | -16.58 Million USD | 74.89% |
| 2010 | -66.05 Million USD | 0.87% |
| 2009 | -66.63 Million USD | -117.0% |
| 2008 | -30.7 Million USD | -34.35% |
| 2007 | -22.85 Million USD | -145.47% |
| 2006 | -9.31 Million USD | 70.43% |
| 2005 | -31.48 Million USD | -310.8% |
| 2004 | -7.66 Million USD | 71.73% |
| 2003 | -27.11 Million USD | -24521.1% |
| 2002 | 111.02 Thousand USD | -94.99% |
| 2001 | 2.21 Million USD | 229.23% |
| 2000 | 673.59 Thousand USD | 161.24% |
| 1999 | -1.1 Million USD | 8.33% |
| 1998 | -1.2 Million USD | 36.84% |
| 1997 | -1.9 Million USD | -138.78% |
| 1996 | 4.9 Million USD | 800.0% |
| 1995 | -700 Thousand USD | 89.86% |
| 1994 | -6.9 Million USD | -76.92% |
| 1993 | -3.9 Million USD | -234.48% |
| 1992 | 2.9 Million USD | 128.43% |
| 1991 | -10.2 Million USD | -292.31% |
| 1990 | -2.6 Million USD | 44.68% |
| 1989 | -4.7 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -245.61 Million USD | -4.89% |
| 2024 Q1 | -234.15 Million USD | 15.44% |
| 2023 Q2 | -170.51 Million USD | -118.3% |
| 2023 Q3 | -202.51 Million USD | -18.77% |
| 2023 Q4 | -276.9 Million USD | -36.73% |
| 2023 FY | -276.9 Million USD | -287.64% |
| 2023 Q1 | -78.1 Million USD | -9.35% |
| 2022 Q2 | -46.5 Million USD | 15.87% |
| 2022 Q3 | -56.59 Million USD | -21.71% |
| 2022 Q4 | -71.43 Million USD | -26.21% |
| 2022 Q1 | -55.27 Million USD | 47.1% |
| 2022 FY | -71.43 Million USD | 31.64% |
| 2021 FY | -104.48 Million USD | 32.45% |
| 2021 Q4 | -104.48 Million USD | 13.14% |
| 2021 Q3 | -120.29 Million USD | 17.14% |
| 2021 Q2 | -145.18 Million USD | 15.29% |
| 2021 Q1 | -171.39 Million USD | -10.81% |
| 2020 Q3 | -156.35 Million USD | 6.35% |
| 2020 Q2 | -166.96 Million USD | -117.97% |
| 2020 Q1 | -76.59 Million USD | -9.21% |
| 2020 FY | -154.67 Million USD | -120.53% |
| 2020 Q4 | -154.67 Million USD | 1.08% |
| 2019 FY | -70.13 Million USD | 20.69% |
| 2019 Q3 | -81.58 Million USD | -19.32% |
| 2019 Q4 | -70.13 Million USD | 14.03% |
| 2019 Q1 | -65.14 Million USD | 26.34% |
| 2019 Q2 | -68.37 Million USD | -4.96% |
| 2018 Q1 | -64.06 Million USD | 12.08% |
| 2018 FY | -88.43 Million USD | -21.37% |
| 2018 Q4 | -88.43 Million USD | -13.17% |
| 2018 Q3 | -78.14 Million USD | -9.96% |
| 2018 Q2 | -71.06 Million USD | -10.93% |
| 2017 FY | -72.86 Million USD | 33.63% |
| 2017 Q3 | -78.61 Million USD | 26.33% |
| 2017 Q1 | -122.68 Million USD | -11.74% |
| 2017 Q4 | -72.86 Million USD | 7.3% |
| 2017 Q2 | -106.7 Million USD | 13.02% |
| 2016 Q2 | -105.7 Million USD | -11.78% |
| 2016 Q4 | -109.79 Million USD | 3.3% |
| 2016 Q1 | -94.55 Million USD | -0.49% |
| 2016 FY | -109.79 Million USD | -16.68% |
| 2016 Q3 | -113.53 Million USD | -7.41% |
| 2015 Q3 | -100.67 Million USD | -20.71% |
| 2015 Q1 | -85.54 Million USD | 7.88% |
| 2015 Q2 | -83.4 Million USD | 2.51% |
| 2015 FY | -94.09 Million USD | -1.32% |
| 2015 Q4 | -94.09 Million USD | 6.54% |
| 2014 FY | -92.86 Million USD | 0.35% |
| 2014 Q2 | -75.83 Million USD | 9.93% |
| 2014 Q3 | -93.85 Million USD | -23.77% |
| 2014 Q4 | -92.86 Million USD | 1.05% |
| 2014 Q1 | -84.19 Million USD | 9.66% |
| 2013 Q2 | -76.96 Million USD | 2.92% |
| 2013 Q3 | -82.59 Million USD | -7.31% |
| 2013 Q4 | -93.19 Million USD | -12.84% |
| 2013 FY | -93.19 Million USD | -6.03% |
| 2013 Q1 | -79.27 Million USD | 9.8% |
| 2012 Q4 | -87.88 Million USD | 1.71% |
| 2012 Q2 | -16.23 Million USD | -3.73% |
| 2012 Q3 | -89.41 Million USD | -450.89% |
| 2012 Q1 | -15.64 Million USD | 5.66% |
| 2012 FY | -87.88 Million USD | -429.89% |
| 2011 FY | -16.58 Million USD | 74.89% |
| 2011 Q3 | -13.95 Million USD | 79.43% |
| 2011 Q4 | -16.58 Million USD | -18.84% |
| 2011 Q1 | -62.87 Million USD | 4.81% |
| 2011 Q2 | -67.85 Million USD | -7.92% |
| 2010 Q1 | -61.2 Million USD | 8.14% |
| 2010 FY | -66.05 Million USD | 0.87% |
| 2010 Q4 | -66.05 Million USD | -3.56% |
| 2010 Q3 | -63.78 Million USD | 1.13% |
| 2010 Q2 | -64.5 Million USD | -5.39% |
| 2009 Q3 | -66.34 Million USD | -21.87% |
| 2009 Q1 | -43.67 Million USD | -42.22% |
| 2009 FY | -66.63 Million USD | -117.0% |
| 2009 Q4 | -66.63 Million USD | -0.44% |
| 2009 Q2 | -54.43 Million USD | -24.66% |
| 2008 Q1 | -3.23 Million USD | 85.82% |
| 2008 FY | -30.7 Million USD | -34.35% |
| 2008 Q2 | -11.1 Million USD | -242.69% |
| 2008 Q3 | -22.81 Million USD | -105.53% |
| 2008 Q4 | -30.7 Million USD | -34.56% |
| 2007 Q4 | -22.85 Million USD | -152.23% |
| 2007 FY | -22.85 Million USD | -145.47% |
| 2007 Q2 | -2.51 Million USD | 59.3% |
| 2007 Q1 | -6.17 Million USD | 33.69% |
| 2007 Q3 | -9.06 Million USD | -260.61% |
| 2006 FY | -9.31 Million USD | 70.43% |
| 2006 Q3 | -6.09 Million USD | 76.58% |
| 2006 Q1 | -28.82 Million USD | 8.44% |
| 2006 Q2 | -26 Million USD | 9.8% |
| 2006 Q4 | -9.31 Million USD | -52.86% |
| 2005 Q1 | -12.3 Million USD | -60.56% |
| 2005 FY | -31.48 Million USD | -310.8% |
| 2005 Q4 | -31.48 Million USD | -115.64% |
| 2005 Q3 | -14.6 Million USD | 22.46% |
| 2005 Q2 | -18.83 Million USD | -53.03% |
| 2004 FY | -7.66 Million USD | 71.73% |
| 2004 Q1 | -7.74 Million USD | 71.42% |
| 2004 Q3 | -10.57 Million USD | -1.53% |
| 2004 Q4 | -7.66 Million USD | 27.54% |
| 2004 Q2 | -10.41 Million USD | -34.43% |
| 2003 Q1 | 1.58 Million USD | 1324.42% |
| 2003 Q3 | 341.31 Thousand USD | -85.87% |
| 2003 FY | -27.11 Million USD | -24521.1% |
| 2003 Q2 | 2.41 Million USD | 52.72% |
| 2003 Q4 | -27.11 Million USD | -8043.51% |
| 2002 Q3 | -747.68 Thousand USD | -127.63% |
| 2002 Q4 | 111.02 Thousand USD | 114.85% |
| 2002 Q1 | 3.31 Million USD | 49.68% |
| 2002 Q2 | 2.7 Million USD | -18.47% |
| 2002 FY | 111.02 Thousand USD | -94.99% |
| 2001 Q1 | -536.1 Thousand USD | -179.59% |
| 2001 Q2 | 1.44 Million USD | 368.97% |
| 2001 Q3 | 2.63 Million USD | 82.59% |
| 2001 Q4 | 2.21 Million USD | -15.77% |
| 2001 FY | 2.21 Million USD | 229.23% |
| 2000 Q2 | -7.73 Million USD | -3.69% |
| 2000 FY | 673.59 Thousand USD | 161.24% |
| 2000 Q4 | 673.59 Thousand USD | 106.48% |
| 2000 Q1 | -7.46 Million USD | -838.21% |
| 2000 Q3 | -10.39 Million USD | -34.38% |
| 1999 Q1 | -500 Thousand USD | 0.0% |
| 1999 Q3 | -1.1 Million USD | -22.22% |
| 1999 Q4 | -795.16 Thousand USD | 27.71% |
| 1999 Q2 | -900 Thousand USD | -80.0% |
| 1999 FY | -1.1 Million USD | 8.33% |
| 1998 Q2 | -600 Thousand USD | 0.0% |
| 1998 Q4 | -500 Thousand USD | 58.33% |
| 1998 FY | -1.2 Million USD | 36.84% |
| 1998 Q1 | -600 Thousand USD | 14.29% |
| 1998 Q3 | -1.2 Million USD | -100.0% |
| 1997 Q3 | -1.9 Million USD | 17.39% |
| 1997 FY | -1.9 Million USD | -138.78% |
| 1997 Q1 | - USD | -100.0% |
| 1997 Q2 | -2.3 Million USD | 0.0% |
| 1997 Q4 | -700 Thousand USD | 63.16% |
| 1996 Q4 | 3.5 Million USD | -28.57% |
| 1996 Q1 | -2.3 Million USD | -2200.0% |
| 1996 Q2 | -4.3 Million USD | -86.96% |
| 1996 Q3 | 4.9 Million USD | 213.95% |
| 1996 FY | 4.9 Million USD | 800.0% |
| 1995 Q1 | -9.7 Million USD | -53.97% |
| 1995 Q2 | -10 Million USD | -3.09% |
| 1995 Q3 | -700 Thousand USD | 93.0% |
| 1995 Q4 | -100 Thousand USD | 85.71% |
| 1995 FY | -700 Thousand USD | 89.86% |
| 1994 FY | -6.9 Million USD | -76.92% |
| 1994 Q4 | -6.3 Million USD | 8.7% |
| 1994 Q3 | -6.9 Million USD | 62.3% |
| 1994 Q2 | -18.3 Million USD | -232.73% |
| 1994 Q1 | -5.5 Million USD | -111.54% |
| 1993 FY | -3.9 Million USD | -234.48% |
| 1993 Q1 | 900 Thousand USD | 126.47% |
| 1993 Q2 | 1.6 Million USD | 77.78% |
| 1993 Q3 | -3.9 Million USD | -343.75% |
| 1993 Q4 | -2.6 Million USD | 33.33% |
| 1992 Q2 | -7.9 Million USD | -113.51% |
| 1992 Q1 | -3.7 Million USD | 55.42% |
| 1992 FY | 2.9 Million USD | 128.43% |
| 1992 Q3 | 2.9 Million USD | 136.71% |
| 1992 Q4 | -3.4 Million USD | -217.24% |
| 1991 Q3 | -10.2 Million USD | -137.21% |
| 1991 Q2 | -4.3 Million USD | 15.69% |
| 1991 Q1 | -5.1 Million USD | -6.25% |
| 1991 FY | -10.2 Million USD | -292.31% |
| 1991 Q4 | -8.3 Million USD | 18.63% |
| 1990 Q2 | -3.4 Million USD | 26.09% |
| 1990 FY | -2.6 Million USD | 44.68% |
| 1990 Q3 | -2.6 Million USD | 23.53% |
| 1990 Q1 | -4.6 Million USD | 9.8% |
| 1990 Q4 | -4.8 Million USD | -84.62% |
| 1989 FY | -4.7 Million USD | 0.0% |
| 1989 Q4 | -5.1 Million USD | -8.51% |
| 1989 Q2 | 100 Thousand USD | 0.0% |
| 1989 Q3 | -4.7 Million USD | -4800.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 10828.516% |
| AngioDynamics, Inc. | -70.14 Million USD | -294.775% |
| AtriCure, Inc. | -9.81 Million USD | -2720.935% |
| Avinger, Inc. | 10.12 Million USD | 2836.196% |
| Azenta, Inc. | -618.47 Million USD | 55.228% |
| BioLife Solutions, Inc. | 7.25 Million USD | 3917.772% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 111.31% |
| Daxor Corporation | 755.65 Thousand USD | 36743.909% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | -18736.939% |
| Femasys Inc. | -15.01 Million USD | -1744.152% |
| GlucoTrack, Inc. | -4.29 Million USD | -6345.601% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 819.415% |
| Hologic, Inc. | 374.4 Million USD | 173.959% |
| ICU Medical, Inc. | 1.45 Billion USD | 119.09% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 89.591% |
| KORU Medical Systems, Inc. | -7.03 Million USD | -3834.891% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | -5251.817% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -6358.459% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -6358.459% |
| Masimo Corporation | 804 Million USD | 134.441% |
| Microbot Medical Inc. | -2.28 Million USD | -12012.992% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | -2785.686% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 191.622% |
| Nephros, Inc. | -2.47 Million USD | -11106.111% |
| NovoCure Limited | 355.42 Million USD | 177.908% |
| NEXGEL, Inc. | 98 Thousand USD | 282654.082% |
| NEXGEL, Inc. | 98 Thousand USD | 282654.082% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 568.89% |
| Pro-Dex, Inc. | 10.91 Million USD | 2636.671% |
| Pulse Biosciences, Inc. | -35.22 Million USD | -686.187% |
| Predictive Oncology Inc. | -5.87 Million USD | -4615.774% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 9241.178% |
| QuidelOrtho Corporation | 2.49 Billion USD | 111.097% |
| Repligen Corporation | -39.51 Million USD | -600.683% |
| Sanara MedTech Inc. | 6.64 Million USD | 4267.155% |
| STAAR Surgical Company | -147.2 Million USD | -88.108% |
| Sharps Technology, Inc. | -3.01 Million USD | -9090.556% |
| Utah Medical Products, Inc. | -92.52 Million USD | -199.27% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 114.092% |
| Jin Medical International Ltd. | -2.81 Million USD | -9731.43% |